Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Addressing Misdiagnosis of Optic Nerve Sheath Meningiomas.

Kalen BD, Hess RA, Abi-Aad KR, Welz ME, Patra DP, Sharma A, Mrugala MM, Porter AB, Bendok BR, Acierno MD.

World Neurosurg. 2020 Jan;133:419-420. doi: 10.1016/j.wneu.2019.10.122. No abstract available.

PMID:
31881557
2.

Clinical evaluation of fitness to drive in patients with brain metastases.

Valencia-Sanchez C, Gorelkin VC, Mrugala MM, Sharma A, Vora SA, Ashman JB, Daniels TB, Halyard MY, Rule WG, Zhang N, Butterfield RJ, Schild SE, Porter AB.

Neurooncol Pract. 2019 Dec;6(6):484-489. doi: 10.1093/nop/npz027. Epub 2019 Jul 3.

PMID:
31832219
3.

Brain metastases from non-small cell lung cancer with EGFR or ALK mutations: A systematic review and meta-analysis of multidisciplinary approaches.

Singh R, Lehrer EJ, Ko S, Peterson J, Lou Y, Porter AB, Kotecha R, Brown PD, Zaorsky NG, Trifiletti DM.

Radiother Oncol. 2019 Dec 5;144:165-179. doi: 10.1016/j.radonc.2019.11.010. [Epub ahead of print] Review.

PMID:
31812932
4.

Expanding the Spectrum of Radiation Necrosis After Stereotactic Radiosurgery (SRS) for Intracranial Metastases From Lung Cancer: A Retrospective Review.

Sharma A, Mountjoy LJ, Butterfield RJ, Zhang N, Ross HJ, Schild SE, Sio TT, Daniels TB, Paripati HR, Mrugala MM, Vora SA, Patel NP, Zimmerman RS, Ashman JB, Porter AB.

Am J Clin Oncol. 2019 Nov 18. doi: 10.1097/COC.0000000000000642. [Epub ahead of print]

PMID:
31764021
5.

Examiner accuracy in cognitive testing in multisite brain-tumor clinical trials: an analysis from the Alliance for Clinical Trials in Oncology.

Cerhan JH, Anderson SK, Butts AM, Porter AB, Jaeckle K, Galanis E, Brown PD.

Neurooncol Pract. 2019 Jul;6(4):283-288. doi: 10.1093/nop/npy048. Epub 2018 Nov 24.

PMID:
31386061
6.

ENvironmental Dynamics Underlying Responsive Extreme Survivors (ENDURES) of Glioblastoma: A Multidisciplinary Team-based, Multifactorial Analytical Approach.

Johnston SK, Whitmire P, Massey SC, Kumthekar P, Porter AB, Raghunand N, Gonzalez-Cuyar LF, Mrugala MM, Hawkins-Daarud A, Jackson PR, Hu LS, Sarkaria JN, Wang L, Gatenby RA, Egan KM, Canoll P, Swanson KR; ENDURES consortium.

Am J Clin Oncol. 2019 Aug;42(8):655-661. doi: 10.1097/COC.0000000000000564.

PMID:
31343422
7.

Malignant Glial Neuronal Tumors After West Nile Virus Neuroinvasive Disease: A Coincidence or a Clue?

Sharma A, Grill MF, Spritzer S, Leis AA, Anderson M, Vig P, Porter AB.

Neurohospitalist. 2019 Jul;9(3):160-164. doi: 10.1177/1941874418819621. Epub 2018 Dec 26.

PMID:
31244973
8.

What is the Role of Tumor-treating Fields in Newly Diagnosed Glioblastoma?

Ornelas AS, Porter AB, Sharma A, Knox MG, Marks LA, Wingerchuk DM, O'Carroll CB.

Neurologist. 2019 Mar;24(2):71-73. doi: 10.1097/NRL.0000000000000222.

PMID:
30817495
9.

Analysis of MRI Volumetric Changes After Hypofractionated Stereotactic Radiation Therapy for Benign Intracranial Neoplasms.

Fega KR, Fletcher GP, Waddle MR, Peterson JL, Ashman JB, Barrs DM, Bendok BR, Patel NP, Porter AB, Vora SA.

Adv Radiat Oncol. 2018 Aug 23;4(1):43-49. doi: 10.1016/j.adro.2018.08.013. eCollection 2019 Jan-Mar.

10.

The Use of Recombinant Poliovirus for the Treatment of Recurrent Glioblastoma Multiforme.

Abi-Aad KR, Turcotte EL, Welz ME, Krishna C, Mrugala MM, Porter AB, Vora SA, Bendok BR.

World Neurosurg. 2019 Jan 22. pii: S1878-8750(19)30147-0. doi: 10.1016/j.wneu.2019.01.050. [Epub ahead of print] No abstract available.

PMID:
30682513
11.

Updated Imaging Features of Dysplastic Cerebellar Gangliocytoma.

Dhamija R, Wood CP, Porter AB, Hu LS, Weindling SM, Hoxworth JM.

J Comput Assist Tomogr. 2019 Mar/Apr;43(2):277-281. doi: 10.1097/RCT.0000000000000814.

PMID:
30407243
12.

Disseminated High-grade Glioma in a Long-term Survivor of Medulloblastoma: Implications and Management of Radiation-induced Malignancies.

Porter AB, Sio TT, Nelson KD, Raghunathan A, Bendok BR, Mrugala MM.

Neurologist. 2018 Nov;23(6):191-193. doi: 10.1097/NRL.0000000000000199.

PMID:
30379742
13.

Neuroimaging abnormalities in patients with Cowden syndrome: Retrospective single-center study.

Dhamija R, Weindling SM, Porter AB, Hu LS, Wood CP, Hoxworth JM.

Neurol Clin Pract. 2018 Jun;8(3):207-213. doi: 10.1212/CPJ.0000000000000463.

14.

Mystery Case: Widespread plexiform neurofibromas in neurofibromatosis type 1: An uncommon cause of back pain.

Grimsrud KW, Porter AB.

Neurology. 2017 Oct 31;89(18):e218-e219. doi: 10.1212/WNL.0000000000004595. No abstract available.

PMID:
29084928
15.

Hybrid whole body 18F-FDG PET/MR in evaluation of plexiform neurofibromatosis type 1.

Yang M, Zhou Y, Hoxworth JM, Porter AB, Roarke MC.

Rev Esp Med Nucl Imagen Mol. 2018 Jul - Aug;37(4):261-263. doi: 10.1016/j.remn.2017.07.003. Epub 2017 Aug 10. English, Spanish. No abstract available.

PMID:
28803890
16.

Treatment of Glioma in the 21st Century: An Exciting Decade of Postsurgical Treatment Advances in the Molecular Era.

Uhm JH, Porter AB.

Mayo Clin Proc. 2017 Jun;92(6):995-1004. doi: 10.1016/j.mayocp.2017.01.010. Review.

PMID:
28578786
17.

Socioeconomic status and glioblastoma risk: a population-based analysis.

Porter AB, Lachance DH, Johnson DR.

Cancer Causes Control. 2015 Feb;26(2):179-185. doi: 10.1007/s10552-014-0496-x. Epub 2014 Nov 25.

PMID:
25421378
18.

Secondary intramedullary spinal cord non-Hodgkin's lymphoma.

Flanagan EP, O'Neill BP, Habermann TM, Porter AB, Keegan BM.

J Neurooncol. 2012 May;107(3):575-80. doi: 10.1007/s11060-011-0781-4. Epub 2011 Dec 22.

PMID:
22189600
19.

Primary intramedullary spinal cord lymphoma.

Flanagan EP, O'Neill BP, Porter AB, Lanzino G, Haberman TM, Keegan BM.

Neurology. 2011 Aug 23;77(8):784-91. doi: 10.1212/WNL.0b013e31822b00b9. Epub 2011 Aug 10.

PMID:
21832220
20.

Del(6)(q22) and BCL6 rearrangements in primary CNS lymphoma are indicators of an aggressive clinical course.

Cady FM, O'Neill BP, Law ME, Decker PA, Kurtz DM, Giannini C, Porter AB, Kurtin PJ, Johnston PB, Dogan A, Remstein ED.

J Clin Oncol. 2008 Oct 10;26(29):4814-9. doi: 10.1200/JCO.2008.16.1455. Epub 2008 Jul 21.

21.

Retrospective review of adjuvant chemotherapy for esthesioneuroblastoma.

Porter AB, Bernold DM, Giannini C, Foote RL, Link MJ, Olsen KD, Moynihan TJ, Buckner JC.

J Neurooncol. 2008 Nov;90(2):201-4. doi: 10.1007/s11060-008-9645-y. Epub 2008 Jul 17.

PMID:
18633576
22.

Primary central nervous system lymphoma can be histologically diagnosed after previous corticosteroid use: a pilot study to determine whether corticosteroids prevent the diagnosis of primary central nervous system lymphoma.

Porter AB, Giannini C, Kaufmann T, Lucchinetti CF, Wu W, Decker PA, Atkinson JL, O'Neill BP.

Ann Neurol. 2008 May;63(5):662-7. doi: 10.1002/ana.21366.

PMID:
18481293
23.

Pharmacologic elevation of blood pressure for acute brain ischemia.

Stead LG, Bellolio MF, Gilmore RM, Porter AB, Rabinstein AA.

Neurocrit Care. 2008;8(2):259-61.

PMID:
17957498
24.

Compulsive urination as a presenting symptom of frontotemporal dementia.

Porter AB, Healy L, Foster NL, Josephs KA.

Eur J Neurol. 2007 Aug;14(8):e16-7. No abstract available.

PMID:
17661991
25.

Changes in ACh levels in the rat brain during subacute administration of diisopropylfluorophosphate.

Lim DK, Porter AB, Hoskins B, Ho IK.

Toxicol Appl Pharmacol. 1987 Sep 30;90(3):477-89.

PMID:
3660414
26.

Lymphatic and portal venous absorption of phenobarbital and thiopental in the dog.

Lowrimore MG, Porter AB, Hume AS.

Arch Int Pharmacodyn Ther. 1987 Jul;288(1):5-10.

PMID:
3662699
27.

Regional and subcellular calmodulin content of rat brain.

Hoskins B, Burton CK, Liu DD, Porter AB, Ho IK.

J Neurochem. 1986 Jan;46(1):303-4.

PMID:
3940289
28.

DOPPLER'S PRINCIPLE AND LIGHT-BEATS.

Porter AB.

Science. 1905 Feb 24;21(530):314-5. No abstract available.

PMID:
17841730
29.

Points on lightning-rods.

Porter AB.

Science. 1884 Sep 12;4(84):223. No abstract available.

PMID:
17730371

Supplemental Content

Loading ...
Support Center